Effects of topoisomerases inhibitors protoberberine on Leishmania donovani growth, macrophage function, and infection

Journal of Parasitology

Volumn 89, Issue 5, 2003, Pages 1048-1052

  Marquis, Jean François ^a   Makhey, Darshan ^a,b,c   La Voie, Edmond J ^a,b,c   Olivier, Martin ^a,d  

^a UNIVERSITÉ LAVAL   (Canada)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEISHMANIAL AGENT; DNA TOPOISOMERASE INHIBITOR; GAMMA INTERFERON; MONOBENZIMIDAZOLE; NITRIC OXIDE; PROTOBERBERINE; TERBENZIMIDAZOLE; UNCLASSIFIED DRUG;

LEISHMANIASIS; PARASITOLOGY;

CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; DRUG SCREENING; DRUG STRUCTURE; GROWTH; IN VITRO STUDY; LEISHMANIA DONOVANI; MACROPHAGE FUNCTION; NONHUMAN; PARASITOSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANIMALS; ANTIPROTOZOAL AGENTS; BENZIMIDAZOLES; BERBERINE ALKALOIDS; DNA TOPOISOMERASES; DOSE-RESPONSE RELATIONSHIP, DRUG; INTERFERON TYPE II; LEISHMANIA DONOVANI; MACROPHAGES; NITRIC OXIDE;

LEISHMANIA DONOVANI; PROTOZOA;

EID: 0344420369     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.1645/GE-3161     Document Type: Conference Paper

References (26)

1. BROCCOLI, S., J. F. MARQUIS, B. PAPADOPOULOU, M. OLIVIER, AND M. DROLET. 1999. Characterization of a Leishmania donovani gene encoding a protein that closely resembles a type IB topoisomerase. Nucleic Acids Research 27: 2745-2752.
2. CHEESMAN, S. 2000. The topoisomerases of protozoan parasites. Parasitology Today 16: 277-281.
3. CHEN, A. Y., C. YU, A. BODLEY, L. F. PENG, AND L. F. LIU. 1993. A new mammalian DNA topoisomerase I poison Hoechst 33342: Cytotoxicity and drug resistance in human cell cultures. Cancer Research 53: 1332-1337.
4. -, -, B. GATTO, AND L. F. LIU. 1993. DNA minor groove-binding ligands: A different class of mammalian DNA topoisomerase I inhibitors. Proceedings of the National Academy of Sciences of the United States of America 90: 8131-8135.
5. DAS, A., A. DASGUPTA, S. SHARMA, M. GHOSH, T. SENGUPTA, S. BANDOPADHYAY, AND H. MAJUMDER. 2001. Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: A key molecular target in antileishmanial therapy. Nucleic Acids Research 29: 1844-1851.
6. EVANS, T. G., L. THAI, D. L. GRANGER, AND J. B. HIBBS. 1993. Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. Journal of Immunology 151: 907-915.
7. HERWALDT, B. L. 1999. Leishmaniasis. Lancet 354: 1191-1199.
8. KIM, J. S., Q. SUN, B. GATTO, C. YU, A. LIU, L. F. LIU, AND E. J. LA VOIE. 1996. Structure-activity relationships of benzimidazoles and related heterocycles as topoisomerase I poisons. Bioorganic and Medicinal Chemistry 4: 621-630.
9. -, C. YU, A. LIU, L. F. LIU, AND E. J. LA VOIE. 1997. Terbenzimidazoles: Influence of 2-, 4-, and 5-substituents on cytotoxicity and relative potency as topoisomerase I poisons. Journal of Medicinal Chemistry 40: 2818-2824.
10. LIU, L. F. 1989. DNA topoisomerase poisons as antitumor drugs. Annual Review of Biochemistry 58: 351-375.
11. MAKHEY, D., B. GATTO, C. YU, A. LIU, L. F. LIU, AND E. J. LA VOIE. 1995. Protoberberine alkaloids and related compounds as dual inhibitors of mammalian topoisomerase I and II. Medicinal Chemistry Research 5: 1-12.
12. -, -, -, -, -, AND -. 1996. Coralyne and related compounds as mammalian topoisomerase I and topoisomerase II poisons. Bioorganic and Medicinal Chemistry 4: 781-791.
13. MANSFIELD, J. M., AND M. OLIVIER. 2002. Immune evasion by parasites. In Immunology of infectious diseases, S. H. E. Kaufmann, A. Sher, and R. Ahmed (eds.). American Society for Microbiology, Washington, D.C., p. 379-392.
14. MARQUIS, J.-F., M. DROLET, AND M. OLIVIER. 2003. Consequence of Hoechst 33342-mediated Leishmania DNA topoisomerase-I inhibition on parasite replication. Parasitology 126: 21-30.
15. MATTE, C., J. F. MARQUIS, J. BLANCHETTE, P. GROS, R. FAURE, B. I. POSNER, AND M. OLIVIER. 2000. Peroxovanadium-mediated protection against murine leishmaniasis: Role of the modulation of nitric oxide. European Journal of Immunology 30: 2555-2564.
16. OLIVIER, M., B. J. ROMERO-GALLO, C. MATTE, J. BLANCHETTE, B. I. POSNER, M. J. TREMBLAY, AND R. FAURE. 1998. Modulation of interferon-γ-induced macrophage activation by phosphotyrosine phosphatases inhibition: Effect on murine leishmaniasis progression. Journal of Biological Chemistry 273: 13944-13949.
17. -, AND C. E. TANNER. 1987. Susceptibilities of macrophage populations to infection in vitro by Leishmania donovani. Infection and Immunity 55: 467-471.
18. RADZIOCH, D., T. HUDSON, M. BOULE, L. BARRERA, J. W. URBANCE, L. VARESIO, AND E. SKAMENE. 1991. Genetic resistance/susceptibility to mycobacteria: Phenotypic expression in bone marrow derived macrophage lines. Journal of Leukocyte Biology 50: 263-272.
19. RANGARAJAN, M., J. KIM, S. JIN, S. SIM, A. LIU, D. PILCH, L. LIU, AND E. J. LA VOIE. 2000. 2″-substituted 5-phenylterbenzimidazoles as topoisomerase I poisons. Bioorganic and Medicinal Chemistry 8: 1371-1382.
20. SUN, Q., B. GATTO, C. YU, A. LIU, L. F. LIU, AND E. J. LA VOIE. 1994. Structure activity of topoisomerase I poisons related to Hoechst 33342. Bioorganic and Medicinal Chemistry Letters 4: 2871-2876.
21. -, -, -, -, -, AND -. 1995. Synthesis and evaluation of terbenzimidazoles as topoisomerase I inhibitors. Journal of Medicinal Chemistry 38: 3638-3644.
22. VILLA, H., A. R. OTERO MARCOS, R. M. REGUERA, R. BALAÑA-FOUCE, C. GARCIA-ESTRADA, Y. PÉREZ-PERTEJO, B. L. TEKWANI, P. J. MYLER, K. D. STUART, M. A. BJORNSTI, AND D. ORDÓÑEZ. 2003. A novel active DNA topoisomerase I in Leishmania donovani. Journal of Biological Chemistry 6: 3521-3526.
23. WANG, J. C. 1985. DNA topoisomerases. Annual Review of Biochemistry 54: 665-697.
24. -. 1996. DNA topoisomerases. Annual Review of Biochemistry 65: 635-692.
25. WANG, L. K., B. D. ROGERS, AND S. M. HECHT. 1996. Inhibition of topoisomerase I function by coralyne and 5,6-dihydrocoralyne. Chemical Research in Toxicology 9: 75-83.
26. WHITE, T. C., F. FASE-FOWLER, H. VAN LUENEN, J. CALAFAT, AND P. BORST. 1988. The H circles of Leishmania tarentolae are a unique amplifiable system of oligomeric DNAs associated with drug resistance. Journal of Biological Chemistry 263: 16977-16983.